Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinepazide Maleate in Acute Ischemic Stroke
NCT04951232Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cinepazide in ischemic stroke (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: modified Rankin Scale at 90 days. Started Jul 2016; status: completed.
02
Drugs
cinepazide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04951232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951232.